期刊文献+

FOXP3^+调节性T细胞及IL-10在弥漫性大B细胞淋巴瘤中的表达及其与预后的关系 被引量:6

Correlation of the expression and prognosis of FOXP3^+ Treg and IL-10 in diffuse large B-cell lymphoma
下载PDF
导出
摘要 目的检测FOXP3+调节性T细胞(Treg)及白介素(IL)-10在弥漫性大B细胞淋巴瘤(DLBCL)组织中的表达情况,探讨其与各临床病理因素及预后的关系。方法采用免疫组化SP法,以FOXP3及IL-10为标志物,对69例DL-BCL组织及26例反应性增生的淋巴结和扁桃体进行染色,对阳性细胞分别进行绝对值计数,同时对69例DLBCL患者进行随访。结果 DLBCL中FOXP3+ Treg细胞数目及IL-10+细胞数目与对照组相比,差异具有统计学意义(P<0.01)。FOXP3+ Treg及IL-10+细胞数目在各临床病理因素间差异无统计学意义(P>0.05)。非GC-DLBCL间质中FOXP3+ Treg数目、GC-DLBCL间质中IL-10阳性细胞数目与预后具有相关性(P<0.05)。结论 FOXP3+ Treg与IL-10可作为DLBCL预后因素之一。 Objective To investigate the expression of FOXP3+Treg and IL-10 in diffuse large B-cell lymphoma(DLBCL)and detecte its clinicopathological significance.Methods The absolute number and correlated to phenotypic and clinical parameters of FOXP3+Treg and IL-10+ cells was studied by immunohistochemical SP methods from 69 patients of DLBCL and 26 cases of normal tonsils and lymph nodes.ROC curves were used to determine prognostic cut-off values of FOXP3+Treg and IL-10+ cells density.Results The absolute number of FOXP3+Treg cells and IL-10+cells in DLBCL was significantly higher than that in normal tonsils and lymph nodes(P〈0.01).The expression of FOXP3+Treg and IL-10 had no relationship to gender,age,clinical stage and pathological subgroup(P〉0.05).The expression of FOXP3+Treg cells in non-GC DLBCL and IL-10+ cells in GC-like DLBCL was correlation to prognosis(P〈0.05).Conclusion The expression of FOXP3+Treg and IL-10 cells serves as a prognostic indicator of DLBCL.
出处 《安徽医科大学学报》 CAS 北大核心 2011年第5期462-466,共5页 Acta Universitatis Medicinalis Anhui
关键词 T淋巴细胞 调节性 白细胞介素10 淋巴瘤 大B细胞 弥漫性 预后 T-lymphocytes regulatory interleukin-10 lymphoma large b-cell diffuse prognosis
  • 相关文献

参考文献13

  • 1夏海龙,陈晓文,陈歆,宋万灯.弥漫性大B细胞淋巴瘤PRDM1基因5′非编码区突变的研究[J].安徽医科大学学报,2010,45(1):27-30. 被引量:4
  • 2Beyer M, Schultze J L. Reguiatotry T cells in cancer [ J ]. Blood, 2006,108 ( 3 ) :804 - 11. 被引量:1
  • 3Petrulio C A, Kim-Schulze S, Kaufman H L. The tumour microenvi- ronment and implications for cancer immunotherapy [ J ]. Expert Opin Biol Ther,2006,6(7 ) :671 - 84. 被引量:1
  • 4Lech-Maranda E, Bienvenu J, Broussais-Guillaumot F, et al. Plasma TNF-alpha and IL-10 level-based prognostic model predicts out- eome of patients with diffuse large B-cell lymphoma in different risk groups defined by the international prognostic index[ J]. Arch Immunol Ther Exp (Warsz) ,2010,58(2) :131 -41. 被引量:1
  • 5Stephens G L,Shevaeh E M. FOXP3 + regulatoiy T cells: selfish- ness under scrutiny[J]. Immunity ,2007,27 ( 3 ) :417 - 9. 被引量:1
  • 6Bluestone J A, Abbas A K. Natural versus adaptive regulatory T cells[J].Nat Rev Immunol,2003,3 (3) :253 - 7. 被引量:1
  • 7Sakaguchi S, Ono M,Setoguchi R,et al. FOXP3 + CD25^+ CD4^+ natural regulatory T cells in dominant self-tolerance and autoim- mune disease[ J]. Immunol Rev,2006 ,212 :8 - 27. 被引量:1
  • 8Banham A H,Powrie F M Suri-Paver E,et al. FOXP3^ + regulatory T cells: Current controversies and future perspectives [ J ]. Eur J Immunol,2006,36 ( 11 ) : 2832 - 6. 被引量:1
  • 9Alvaro T, Lejeune M, Salvado M T, et al. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cy- totoxic and regulatory T cells[ J ]. Clin Cancer Res,2005,11 (4) : 1467 - 73. 被引量:1
  • 10Hasselblom S, Sigurdadottir M, Hansson U, et al. The number of tumour-infiltrating TIA-1^ + cytotoxic T cells but not FOXP3^+ regu- latory T ceils predicts outcome in diffuse large B-cell lymphoma [J]. Br J Haematol,2007,137(4) :364 -73. 被引量:1

二级参考文献19

  • 1闵大六,周晓燕,杨文涛,孙孟红,陆洪芬,张太明,郑爱华,曹裴珍,施达仁.B细胞性非霍奇金淋巴瘤中BCL-6基因5′-非编码区突变[J].中华病理学杂志,2004,33(3):238-241. 被引量:6
  • 2夏海龙,陈丽娟,陈冰,金晓龙,陈赛娟.用比较基因组杂交技术研究弥漫大B细胞淋巴瘤分子细胞遗传学异常及其意义(英文)[J].中华医学遗传学杂志,2006,23(1):12-15. 被引量:4
  • 3Ye B H,Lista F,Lo Coco F,et al. Aherations of a zinc finger-encoding gene, bcl-6, in diffuse large-cell lyre phoma [ J ]. Science, 1993,262 (5134) :747 -50. 被引量:1
  • 4Sanchez Beato M, Sanchez Aguilera A, Piris M A, et al. Cell cycle deregulation in B-cell lymphomas [ J ]. Blood, 2003 ( 4 ), 101 ( 4 ) : 1220 - 35. 被引量:1
  • 5Rao P H, Houldsworth J, Dyomina K, et al. Chromosomal and Gene Amplification in Diffuse Large B-Cell Lymphoma[ J ]. Blood, 1998,92( 1 ) :234 -40. 被引量:1
  • 6Merup M, Moreno T C, Heyman M, et al. 6q deletions in acute lymphoblastic leukaemia and non-Hodgkin's lymphomas[ J]. Blood, 1998,91 ( 11 ) :3397 -400. 被引量:1
  • 7Outi M, Heikki J, Kaarle F, et al. DNA Copy Number Changes in Diffuse Large B-Cell Lymphoma-Comparative Genomic Hybridization Study[J]. Blood, 1996,87(12) : 5269 - 78. 被引量:1
  • 8Mock B A,Liu L,Le Paslier D,et al. The B-lymphocyte maturation promoting transcription factor BLIMP1/PRDI-BF1 maps to D6S447 on human chromosome 6q21-q22. 1 and the syntenic region of mouse chromosome 10 [ J ]. Genomics, 1996,37 ( 1 ) : 24 - 8. 被引量:1
  • 9Harris N L. The World Health Organization classification of neoplastic disease of the haematopoitic and lymphoid tissues : report of the Clinical Advisory Committee Meeting, Aidie House Virginia, November 1997[ J]. Histopathology,2000,36( 1 ) :69 -160. 被引量:1
  • 10Bea S, Zettl A, Wright G, et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expres-sion based survival prediction [ J ]. Blood,2005,106(9) :3183 -90. 被引量:1

共引文献3

同被引文献61

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部